Biogen Idec (NASDAQ:BIIB) EVP Stuart Kingsley sold 8,428 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $336.83, for a total transaction of $2,838,803.24. Following the sale, the executive vice president now directly owns 3,511 shares in the company, valued at approximately $1,182,610. Biogen Idec Inc (NASDAQ:BIIB) stock opened today at $334.83 and is currently trading at $349.00. The stock showed a positive weekly performance of 1.14%.
Zogenix, Inc. (NASDAQ:ZGNX) results for FY2013 were nominal to disappointing. Zogenix is focused on developing and commercializing pain relief medications and drugs for central nervous system disorders. Zogenix, Inc. (NASDAQ:ZGNX) stock opened at $3.54, in current trading session and currently is at $3.69, by gaining 4.38%.The 52 week range of $1.25-$5.19. Company’s market capitalization is $516.29 million.
Geron Corp. (NASDAQ:GERN)‘s stock had its “positive” rating reiterated by equities research analysts at Wells Fargo & Co. in a research note issued to investors on Thursday, American Banking News.com reports. Geron Corporation (NASDAQ:GERN) stock is currently trading at $1.93 .The EPS of the stock is -0.35. Company’s market capitalization is $283.33 million.
Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost bought 37,000 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were purchased at an average price of $9.32 per share, with a total value of $344,840.00. Following the completion of the transaction, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $18,523,500. Opko Health Inc. (NYSE:OPK) stock opened the session at $9.77, and now is at $10.15. The 52 week range of the OPK stock remained $6.14-$12.95 and the day range was $9.76-$10.15.
Leave a Reply